Literature DB >> 17397008

Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.

Jennifer E Snyder-Cappione1, Douglas F Nixon, Christopher P Loo, Joan M Chapman, Duncan A Meiklejohn, Fernando F Melo, Priscilla R Costa, Johan K Sandberg, Denise S Rodrigues, Esper G Kallas.   

Abstract

Mycobacterium tuberculosis (MTB) is a leading cause of mortality worldwide from an infectious agent. Natural killer T (NKT) cells recognize mycobacterial antigens and contribute to anti-MTB immunity in mouse models. NKT cells were measured in subjects with pulmonary tuberculosis, MTB-exposed individuals, and healthy controls. NKT cell levels are selectively lower in peripheral blood mononuclear cells from individuals with pulmonary tuberculosis than in both MTB-exposed subjects and healthy control subjects. This apparent loss of NKT cells from the peripheral blood is sustained during the 6 months after the initiation of MTB treatment. These findings indicate that NKT cells may be an important component of antituberculosis immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397008     DOI: 10.1086/513567

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.

Authors:  Seung-Jung Kee; Yong-Soo Kwon; Yong-Wook Park; Young-Nan Cho; Sung-Ji Lee; Tae-Jong Kim; Shin-Seok Lee; Hee-Chang Jang; Myung-Geun Shin; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

2.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

3.  Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.

Authors:  Karina I Carvalho; Fernanda R Bruno; Jennifer E Snyder-Cappione; Solange M Maeda; Jane Tomimori; Marilia B Xavier; Patrick A Haslett; Douglas F Nixon; Esper G Kallas
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

4.  Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Tiffaney L Vincent; Lan Wu; Luc Van Kaer
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

5.  Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Authors:  L C Ndhlovu; J E Snyder-Cappione; K I Carvalho; F E Leal; C P Loo; F R Bruno; A R Jha; D Devita; A M Hasenkrug; H M R Barbosa; A C Segurado; D F Nixon; E L Murphy; E G Kallas
Journal:  Clin Exp Immunol       Date:  2009-09-02       Impact factor: 4.330

Review 6.  A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.

Authors:  Sandhya Vasan; Moriya Tsuji
Journal:  Semin Immunol       Date:  2009-12-04       Impact factor: 11.130

Review 7.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

8.  Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).

Authors:  Karina I Carvalho; Karina M Melo; Fernanda R Bruno; Jennifer E Snyder-Cappione; Douglas F Nixon; Beatriz T Costa-Carvalho; Esper G Kallas
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

9.  Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro.

Authors:  Venkata Ramanarao Parasa; Anbalagan Selvaraj; Rajasekaran Sikhamani; Alamelu Raja
Journal:  Clin Exp Med       Date:  2014-04-20       Impact factor: 3.984

Review 10.  Nonclassical T cells and their antigens in tuberculosis.

Authors:  Gennaro De Libero; Amit Singhal; Marco Lepore; Lucia Mori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-24       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.